Snowball logo
logo
KROS_logo

Keros Therapeutics, Inc

KROS โ€ข NASDAQ
$15.89+$0.19ย  (1.21%)
Start your journey to financial independence โœจ
Snowball will help you to track your portfolio, plan deposits to your brokerage account and support your passive income strategy with tools and community of investors
Start

Frequently asked questions

What sector does Keros Therapeutics, Inc (KROS) operate in?

Keros Therapeutics, Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Keros Therapeutics, Inc (KROS) current stock price?

As of the latest data, Keros Therapeutics, Inc stock price is $15.89, with a previous close of $15.70. Keros Therapeutics, Inc gained $0.19 in the last trading session, representing a 1.21% increase.

What is Keros Therapeutics, Inc (KROS) current market capitalization?

Keros Therapeutics, Inc market cap is approximately 645.38 million.

What is Keros Therapeutics, Inc (KROS) Earnings Per Share (EPS)?

The trailing EPS is $0.32, and the forward EPS is -$4.01.

What is Keros Therapeutics, Inc (KROS) Price-to-Earnings (P/E) ratio?

Keros Therapeutics, Inc current P/E ratio is 49.66.

What is Keros Therapeutics, Inc (KROS) EBITDA?

Keros Therapeutics, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -39.82 million.

Does Keros Therapeutics, Inc (KROS) pay dividends?

No. Keros Therapeutics, Inc does not pay a dividend.

How did Keros Therapeutics, Inc (KROS) perform in its most recent earnings report?

In the last report (June 30, 2025), Keros Therapeutics, Inc posted an EPS surprise of 32.74% and a revenue surprise of 331.22%.

When is Keros Therapeutics, Inc (KROS) next earnings report?

Keros Therapeutics, Inc is expected to release its next earnings report on September 30, 2025.

What is Keros Therapeutics, Inc (KROS) beta (volatility) score?

Keros Therapeutics, Inc has a beta of 1.067, meaning its volatility is roughly in line with the market.